Our Funds
Since 2010, OneVentures has launched 7 funds, 5 of which are active, managing over AU$900M across multiple sectors and strategies.
ACTIVELY INVESTING
Launched: 2024
1V Growth Fund VII
Building on the success of our earlier equity funds covering technology – Fund I, II, and V, the 1V Growth Fund VII will invest in technology or tech-enabled growth companies with quality, foundational leadership teams, large addressable markets, and global potential.
We are looking to invest between $10M to $30M per company, in high-quality scale-up technology businesses that may have fallen outside of the traditional VC laneway. Those that are, looking for later rounds of financing or have bootstrapped to a later stage, or need support with corporate restructuring and offshore market entry. OneVentures’ operational and strategic expertise is provided in partnership with our portfolio companies’ leadership teams, helping them unlock their full potential.
Our investment strategy focuses on the Australian and New Zealand markets, targeting B2B technology companies that play into global growth thematics, offering innovative products or services that benefit society positively, meeting our ESG criteria. The fund preferences businesses with recurring revenue usage, typically a minimum of $5M to $15M, or subscription-based SaaS models.
ACTIVELY INVESTING
Launched: 2023
Growth Credit Fund VI
The fund follows on from the success of our earlier growth credit funds, and the growing awareness and adoption of growth credit in Australia. Like the previous funds, this fund will continue to provide a compelling risk / return profile for investors, whilst enabling founders access to capital with the need for diluting equity.
The fund is providing facilities from $1-20M, focused on rapidly growing companies that are differentiated through technological innovation. In particular, OneVentures is looking for companies operating in the SaaS, fintech and marketplace sub-sectors, who are led by exceptional founding teams and generating $3-5M ARR.
OneVentures’ new Growth Credit Fund provides a compelling risk / return profile from an asset class which is experiencing increased adoption in a growing market by a manager with unrivalled experience and proven track record. Having completed first close, Fund VI is on track to meet its target of $150M.
ACTIVELY INVESTING
Launched: 2020
Growth Fund V
The OneVentures Growth Fund V reached final close on 31 May 2022 raising $142M.
The fund focusses on technology, tech-enabled and healthcare growth stage companies investing up to $20M+ per company. The companies are high quality scale-up technology businesses but may have fallen outside of the traditional VC mandate, bootstrapped or require support with corporate restructuring, offshore market entry and expertise to accelerate their next phase of growth. OneVentures’ operational and strategic expertise is provided in partnership with the leadership teams of our portfolio companies helping them to unlock their full potential.
The investment strategy for the fund considers major global thematics such as remote workforces, pandemic disruption, rapid digitisation of global economies, clean energy transition, urbanisation, ageing populations, access to education and affordable healthcare. Companies selected for the portfolio provide an innovative product or service with a positive benefit to society. Examples of company opportunities may be in collaboration tools, remote workforce management, aged and disability care, food production, platforms servicing healthcare and education, the enterprise cloud, logistics, property and infrastructure optimisation and management, robotics and automation, Internet of Things (IoT and sensors), big data and artificial intelligence (AI). The fund has a preference for subscription based/recurrent revenue business models.
ACTIVELY INVESTING
Launched: 2021
VGF Credit Fund
In partnership with Invest Vic, the VGF Credit Fund launched its $30M fund in November 2021. The fund has a similar mandate with the Growth Credit Fund IV but is specifically targeting companies in Victoria.
The fund is seeking technology companies with strong product market fit and recurrent revenue models, generating >$3M in revenue. The fund will invest between $500K to $6M per company and will be able to invest together with Growth Credit Fund IV for larger investments.
Funds Allocated
Launched: 2020
Growth Credit Fund IV
The OneVentures Growth Credit Fund IV reached final close on 20 April 2020 raising $78M. The fund is a collaboration with Viola Credit of Israel and will provide circa $120M in debt financing for high-growth technology companies predominantly in Australia and New Zealand.
The fund is focused on rapidly growing companies that are differentiated through technological innovation, with strong revenue growth. In particular, OneVentures is looking for companies operating in the SaaS, fintech, marketplace and e-commerce spaces, who are led by exceptional founding teams and generating >$3-5M in revenue.
Growth credit (also referred to as debt) is attractive to companies seeking a less dilutive financing option, or companies looking to incorporate debt within the funding mix of their capital raising round. It provides a longer capital runway, allowing companies more time to achieve important milestones before a subsequent round of financing. In the same way as our equity investments, the OneVentures team will continue to provide insight, network and strategic knowledge to the investee company.
The fund is seeking technology companies with a strong product market fit, investing $500K to $10M per company and making approximately 20 investments.
Funds Allocated
Launched: 2016
Healthcare Fund III
In December 2016 OneVentures launched its $170M Healthcare Fund III. This fund invested in therapeutics, devices and diagnostics at or near clinical development with a clear commercial, regulatory and reimbursement pathway; and well-defined value inflection and exit points on deal entry.
The fund invested $10M to $20M per company in Australian domiciled companies. The OneVentures team provides support to drive these opportunities through the clinical, regulatory and reimbursement processes to achieve prominence in global markets.
The fund is licensed under the Commonwealth Government’s Biomedical Translation Fund (BTF) programme. The BTF programme was established to provide a pool of public and private funds for investment in promising biomedical innovations with commercialisation potential managed by leading Australian venture firms. OneVentures was granted an $85M license supported by matching capital from its private investor network. The BTF funding provides benefits to investors both during the investment phase and on realisation.
Funds allocated
Launched: 2014
Innovation & Growth Fund II
The OneVentures Innovation & Growth Fund II was launched in October 2014 with $75M in funds available for investment in technology and healthcare businesses.
Fund II focused on later stage companies seeking growth and development capital including for offshore expansion – technology companies with a strong product market fit and a clear path to revenue of $3 to 5M over the following 12 months. In particular, OneVentures looked at investment opportunities where the experience of the OneVentures management team could be leveraged to accelerate value creation and company success. The fund invested on average $5M and up to $10M into any one company.
Funds allocated
Launched: 2010
Innovation Fund I
The OneVentures Innovation Fund is a $40M venture capital fund established to provide capital and expertise to early stage (seed and Series A companies). This fund was launched in 2010 with the Commonwealth Government committing $20M from its Innovation Investment Fund programme matched by $20M capital from private sector investors. Capital from this fund is fully deployed.